帕罗西汀与雷沙吉兰联用在一名帕金森病患者中诱发了血清素综合征。 - Suppr

Suppr

超能文献

Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient.

作者信息

Hébant B, Guillaume M, Desbordes M, Gaillon G, Maltête D, Lefaucheur R

机构信息

Department of Neurology, Rouen University Hospital, 1, rue de Germont, 76031 Rouen cedex, France.

Department of Psychiatry, Rouen University Hospital, 1, rue de Germont, 76031 Rouen cedex, France.

出版信息

Rev Neurol (Paris). 2016 Dec;172(12):788-789. doi: 10.1016/j.neurol.2016.10.002. Epub 2016 Nov 9.

DOI:10.1016/j.neurol.2016.10.002

PMID:27838092

Abstract

摘要

相似文献

Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient.

Rev Neurol (Paris). 2016 Dec;172(12):788-789. doi: 10.1016/j.neurol.2016.10.002. Epub 2016 Nov 9.

Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.

Mov Disord. 2013 Sep;28(10):1464. doi: 10.1002/mds.25416. Epub 2013 Mar 13.

Rasagiline-induced serotonin syndrome.

Mov Disord. 2011 Mar;26(4):766-7. doi: 10.1002/mds.23649. Epub 2011 Mar 2.

Severe serotonin toxicity and manic switch induced by combined use of tramadol and paroxetine.

Aust N Z J Psychiatry. 2007 Feb;41(2):192-3.

Linezolid and Rasagiline - A culprit for serotonin syndrome.

Indian J Pharmacol. 2016 Jan-Feb;48(1):91-2. doi: 10.4103/0253-7613.174573.

Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine.

J Clin Psychopharmacol. 2006 Dec;26(6):681-3. doi: 10.1097/01.jcp.0000239793.29449.75.

Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.

J Neural Transm (Vienna). 2008;115(1):107-16. doi: 10.1007/s00702-007-0811-8. Epub 2007 Sep 7.

Recognition and treatment of serotonin syndrome.

Can Fam Physician. 2008 Jul;54(7):988-92.

Immediate switching from moclobemide to duloxetine may induce serotonin syndrome.

J Clin Psychiatry. 2006 Nov;67(11):1821-2. doi: 10.4088/jcp.v67n1122f.

Delirium associated with paroxetine in an elderly depressive patient: a case report.

Pharmacopsychiatry. 2007 Sep;40(5):199-200. doi: 10.1055/s-2007-985882.

引用本文的文献

A Case Report on Serotonin Syndrome in a Patient With Parkinson's Disease: Diagnostic and Management Challenges.

Cureus. 2023 Mar 28;15(3):e36780. doi: 10.7759/cureus.36780. eCollection 2023 Mar.

Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson's Disease.

Front Behav Neurosci. 2019 Aug 2;13:176. doi: 10.3389/fnbeh.2019.00176. eCollection 2019.

Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques.

Ther Adv Psychopharmacol. 2019 Mar 11;9:2045125318818814. doi: 10.1177/2045125318818814. eCollection 2019.

Interaction between Monoamine Oxidase B Inhibitors and Selective Serotonin Reuptake Inhibitors.

Can J Hosp Pharm. 2018 May-Jun;71(3):196-207. Epub 2018 Jun 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient.

作者信息

Hébant B, Guillaume M, Desbordes M, Gaillon G, Maltête D, Lefaucheur R

机构信息

Department of Neurology, Rouen University Hospital, 1, rue de Germont, 76031 Rouen cedex, France.

Department of Psychiatry, Rouen University Hospital, 1, rue de Germont, 76031 Rouen cedex, France.

出版信息

Rev Neurol (Paris). 2016 Dec;172(12):788-789. doi: 10.1016/j.neurol.2016.10.002. Epub 2016 Nov 9.

DOI:10.1016/j.neurol.2016.10.002

PMID:27838092

Abstract

摘要

相似文献

Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient.

Rev Neurol (Paris). 2016 Dec;172(12):788-789. doi: 10.1016/j.neurol.2016.10.002. Epub 2016 Nov 9.

Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.

Mov Disord. 2013 Sep;28(10):1464. doi: 10.1002/mds.25416. Epub 2013 Mar 13.

Rasagiline-induced serotonin syndrome.

Mov Disord. 2011 Mar;26(4):766-7. doi: 10.1002/mds.23649. Epub 2011 Mar 2.

Severe serotonin toxicity and manic switch induced by combined use of tramadol and paroxetine.

Aust N Z J Psychiatry. 2007 Feb;41(2):192-3.

Linezolid and Rasagiline - A culprit for serotonin syndrome.

Indian J Pharmacol. 2016 Jan-Feb;48(1):91-2. doi: 10.4103/0253-7613.174573.

Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine.

J Clin Psychopharmacol. 2006 Dec;26(6):681-3. doi: 10.1097/01.jcp.0000239793.29449.75.

Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.

J Neural Transm (Vienna). 2008;115(1):107-16. doi: 10.1007/s00702-007-0811-8. Epub 2007 Sep 7.

Recognition and treatment of serotonin syndrome.

Can Fam Physician. 2008 Jul;54(7):988-92.

Immediate switching from moclobemide to duloxetine may induce serotonin syndrome.

J Clin Psychiatry. 2006 Nov;67(11):1821-2. doi: 10.4088/jcp.v67n1122f.

Delirium associated with paroxetine in an elderly depressive patient: a case report.

Pharmacopsychiatry. 2007 Sep;40(5):199-200. doi: 10.1055/s-2007-985882.

引用本文的文献

A Case Report on Serotonin Syndrome in a Patient With Parkinson's Disease: Diagnostic and Management Challenges.

Cureus. 2023 Mar 28;15(3):e36780. doi: 10.7759/cureus.36780. eCollection 2023 Mar.

Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson's Disease.

Front Behav Neurosci. 2019 Aug 2;13:176. doi: 10.3389/fnbeh.2019.00176. eCollection 2019.

Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques.

Ther Adv Psychopharmacol. 2019 Mar 11;9:2045125318818814. doi: 10.1177/2045125318818814. eCollection 2019.

Interaction between Monoamine Oxidase B Inhibitors and Selective Serotonin Reuptake Inhibitors.

Can J Hosp Pharm. 2018 May-Jun;71(3):196-207. Epub 2018 Jun 28.